✦ LIBER ✦

CSF α-synuclein, BETA-AMYLOID 1-42 and tau proteins: Relationship to clinical parameters in early Parkinson's disease

✍ Scribed by Kang, Ju Hee; Chen-Plotkin, Alice; Irwin, David; Siderowf, Andrew; Caspell, Chelsea; Coffey, Chris; Taylor, Peggy; Frasier, Mark; Marek, Kenneth; Mollenhauer, Brit; Trojanowski, John; Shaw, Leslie

Book ID: 122225632
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 251 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.08.089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tau protein and beta-amyloid1-42CSF leve

Tau protein and beta-amyloid1-42CSF levels in different phenotypes of Parkinson’s disease

✍ Hana Přikrylová Vranová; Jan Mareš; Petr Hluštík; Martin Nevrlý; David Stejskal; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 289 KB

Association of Cerebrospinal Fluid β-Amy

Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau 181 , and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

✍ Kang, Ju-Hee 📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 413 KB

P2-163: CSF beta-Amyloid1-42 peptide and

P2-163: CSF beta-Amyloid1-42 peptide and total tau protein as predictors of Alzheimer’s disease in patients with mild cognitive impairment

✍ Katharina Buerger; Niels Andreasen; Stefan J. Teipel; Yong Shen; Yansheng Du; Ka 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Corrigendum to “Prolyl oligopeptidase co

Corrigendum to “Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases” [Neuroscience 242 (2013) 140–150]

✍ Hannula, M.J.; Myöhänen, T.T.; Tenorio-laranga, J.; Männistö, P.T.; Garcia-horsm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 42 KB